Testing effectiveness (Phase 2)Study completedNCT01075100What this trial is testingIxabepilone + Carboplatin Metastatic Breast CancerWho this might be right forMetastatic Breast Cancer US Oncology Research 103
Testing effectiveness (Phase 2)UnknownNCT03412955What this trial is testingA Pilot Study of Eribulin in Breast Cancer (BC) Patients With Brain Metastases Previously Treated With Anthracyclines and TaxanesWho this might be right forBreast Cancer Tan Tock Seng Hospital 14
Not applicableActive Not RecruitingNCT02401685What this trial is testingPOSNOC - A Trial Looking at Axillary Treatment in Early Breast CancerWho this might be right forBreast Cancer University Hospitals of Derby and Burton NHS Foundation Trust 1,900
Testing effectiveness (Phase 2)WithdrawnNCT00397501What this trial is testingBBBD Followed By Methotrexate and Carboplatin With or Without Trastuzumab in Treating Women With Breast Cancer That Has Spread to the BrainWho this might be right forBrain and Central Nervous System TumorsBreast CancerCognitive/Functional Effects+2 more OHSU Knight Cancer Institute
Testing effectiveness (Phase 2)Ended earlyNCT03009058What this trial is testingStudy of IMM 101 in Combination With Standard of Care in Patients With Metastatic or Unresectable CancerWho this might be right forMetastatic Cancer Immodulon Therapeutics Ltd 2
Large-scale testing (Phase 3)Study completedNCT01216111What this trial is testingAdjuvant Platinum and Taxane in Triple-negative Breast Cancer (PATTERN)Who this might be right forTriple Negative Breast Cancer Fudan University 647
Early research (Phase 1)Study completedNCT00514306What this trial is testingStudy of Intermittent OSI-906 DosingWho this might be right forAdvanced Solid Tumors Astellas Pharma Inc 79
Not applicableUnknownNCT04137406What this trial is testingRole of SIRT1 in Regulation of Epithelial-to-mesenchymal Transition in Breast Cancer Lymph Nodes MetastasisWho this might be right forBreast CancerLymph Node Metastases Peking University People's Hospital 160
Not applicableLooking for participantsNCT05573893What this trial is testingPROVIDENCE - Prospective Non-interventional Study (NIS) to Examine Patient-reported Outcomes and Real-world Clinical Data in Patients With HER2-positive, HER2-low or HER2-ultralow Unresectable or Metastatic Breast Cancer Treated With Trastuzumab DeruxtecanWho this might be right forBreast NeoplasmsBreast CancerNeoplasm Metastasis AstraZeneca 800
Testing effectiveness (Phase 2)Study completedNCT00587964What this trial is testingPhase II Trial of Stereotactic Radiosurgery Boost Following Surgical Resection for Brain MetastasesWho this might be right forBrain MetastasisBladder CancerBreast Cancer+10 more Memorial Sloan Kettering Cancer Center 51
Testing effectiveness (Phase 2)Study completedNCT00041808What this trial is testingMagnetic-Targeted Doxorubicin in Treating Patients With Cancer Metastatic to the LiverWho this might be right forMetastases, NeoplasmColorectal NeoplasmsEsophageal Neoplasms+9 more FeRx 20
Not applicableUnknownNCT06230250What this trial is testingUnilateral Secondary Breast Reconstruction Using a Muscle-sparing Pedicled Dorsal Flap After Breast CancerWho this might be right forPatient Satisfaction University Hospital, Brest 22
Not applicableStudy completedNCT02536625What this trial is testingStudy of the Impact of Everolimus Treatment on Lymphocytes NK (Natural Killer) Development and Functions for Patients With a Metastatic Breast Cancer (HR+ / HER2/Neu Negative)Who this might be right forBreast Cancer Centre Leon Berard 62
Early research (Phase 1)Ended earlyNCT01891669What this trial is testingPF-06263507 In Patients With Advanced Solid TumorsWho this might be right forNeoplasmsCarcinoma, Non Small Cell LungBreast Neoplasms+1 more Pfizer 26
Large-scale testing (Phase 3)Study completedNCT00078572What this trial is testingCapecitabine (XELODA) With Or Without Lapatinib (GW572016) For Women With Refractory Advanced or Metastatic Breast CancerWho this might be right forBreast Cancer GlaxoSmithKline 408
Not applicableLooking for participantsNCT03694756What this trial is testingTMEM-MRI: A Pilot Feasibility Study of MRI for Imaging of TMEM in Patients With Operable Breast CancerWho this might be right forBreast Cancer Montefiore Medical Center 95
Not applicableStudy completedNCT03280719What this trial is testingWhole Breast + Lymph Node Irradiation: Prone Compared to Supine Position in 15 or 5 FractionsWho this might be right forBreast NeoplasmsRadiotherapyLymph Node Metastases University Hospital, Ghent 61
Testing effectiveness (Phase 2)Ended earlyNCT02003092What this trial is testingRX-5902 Treatment of Subjects With Triple Negative Breast CancerWho this might be right forSolid TumorTriple Negative Breast Cancer Rexahn Pharmaceuticals, Inc. 18
Not applicableLooking for participantsNCT06805812What this trial is testingPredicting clinicAL outcoMes During First-line CDK4/6 Inhibitors Plus Endocrine Therapy in Patients With Advanced Hormone REceptor-poSitive HER2-negative Breast Cancer: the Retrospective-prospective Multicenter Italian PALMARES-2 StudyWho this might be right forBreast AdenocarcinomaBreast Cancer Stage IVBreast Cancer, Metastatic+38 more Fondazione IRCCS Istituto Nazionale dei Tumori, Milano 3,500
Testing effectiveness (Phase 2)Study completedNCT03658967What this trial is testingClinical Study With Lymfactin® in the Treatment of Patients With Secondary Lymphedema (AdeLE)Who this might be right forSecondary Lymphedema Herantis Pharma Plc. 39